D.A. Davidson Maintains Usana Health Sciences(USNA.US) With Hold Rating, Cuts Target Price to $35
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35
Usana Health Sciences Analyst Ratings
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38
USANA Health Sciences Has Expectation for a Continued Challenging Operating Environment Across Many Markets
USANA Health Sciences: 2Q Operating Results Were Below Our Expectations >USNA
DA Davidson: Maintaining the Usana Health Sciences (USNA.US) rating, adjusted from neutral to neutral, and adjusted the target price from $48.00 to $46.00.
Usana Health Sciences Analyst Ratings
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $46
Usana Health Sciences Analyst Ratings
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $53
Usana Health Sciences Analyst Ratings
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56
DA Davidson Adjusts USANA Health Sciences' Price Target to $52.50 From $49, Keeps Neutral Rating
Usana Health Sciences Analyst Ratings
DA Davidson Adjusts USANA Health Sciences' Price Target to $49 From $57, Keeps Neutral Rating